Montelukast Sodium
Product Images NDC 53002-4441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53002-4441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530024441)

Label Image (Lbl530024441)
Montelukast Sodium product label from RPK Pharmaceuticals, Inc., including the NDC 53002-4441. The label references Fl uconazole 200 mg tablets in a 30-tablet package. It includes details such as barcodes, lot number, expiration date, and instructions to take as directed, along with spaces for clinic and patient information.*
FDA Label Image

Figure1 (Montelukast Fig1)

Figure1 (Montelukast Fig1)
A line graph titled 'Change in Height (cm) from Randomization Visit by Scheduled Week' comparing treatment groups Montelukast 5 mg, Beclomethasone 336 mcg, and Placebo over 56 weeks. The y-axis shows change in height (cm) from -3 to 7, and the x-axis shows weeks on treatment from -19 to 56. All groups show gradual height increase over time with Montelukast and Placebo close in values, and Beclomethasone slightly lower. Standard errors are noted as too small to display.*
FDA Label Image

Figure2 (Montelukast Fig2)

Figure2 (Montelukast Fig2)
A line graph titled 'FEV1 Mean Percent Change from Baseline' comparing Montelukast Sodium and placebo over 15 weeks in a U.S. trial. The x-axis shows weeks in treatment, and the y-axis shows mean percent change from baseline. Montelukast Sodium shows a greater increase compared to placebo, peaking around week 12 and slightly declining by week 15 (washout).*
FDA Label Image

Chemical Structure (Montelukast Str)

Chemical Structure (Montelukast Str)
Chemical structure of montelukast sodium, showing its molecular components including aromatic rings, sulfur atom, and carboxylate sodium salt group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.